International Federation of Gynecology and Obstetrics Global Declaration on Cervical Cancer Elimination.
出版信息
Rev Bras Ginecol Obstet. 2019 Feb;41(2):102-103. doi: 10.1055/s-0039-1679865. Epub 2019 Feb 20.
Abstract
摘要
相似文献
1
International Federation of Gynecology and Obstetrics Global Declaration on Cervical Cancer Elimination.国际妇产科联盟关于消除宫颈癌的全球宣言。
Rev Bras Ginecol Obstet. 2019 Feb;41(2):102-103. doi: 10.1055/s-0039-1679865. Epub 2019 Feb 20.
2
Global elimination of cervical cancer is achievable-with commitment.全球消除宫颈癌是可以实现的——只要有决心。
Lancet Oncol. 2019 Nov;20(11):1467. doi: 10.1016/S1470-2045(19)30647-3.
3
Women's health is now core business and a global health issue.妇女健康现已成为核心业务及全球性健康问题。
Collegian. 2012;19(1):1-3. doi: 10.1016/j.colegn.2012.01.001.
4
A vision for FIGO.
Int J Gynaecol Obstet. 2007 May;97(2):82-5. doi: 10.1016/j.ijgo.2007.01.015. Epub 2007 Mar 23.
5
Executive summary.执行摘要。
Vaccine. 2012 Nov 20;30 Suppl 4:xi. doi: 10.1016/S0264-410X(12)01439-9.
6
The Global Alliance for Vaccines and Immunization (GAVI).全球疫苗免疫联盟（GAVI）。
Vaccine. 2012 Nov 20;30 Suppl 4:x. doi: 10.1016/S0264-410X(12)01438-7.
7
The role of FIGO in the advancement of women's health - in the year 2000.国际妇产科联盟（FIGO）在2000年对促进女性健康所发挥的作用。
Int J Gynaecol Obstet. 2000 Jul;70(1):175-82. doi: 10.1016/s0020-7292(00)00239-3.
8
Overcoming barriers to the eradication of cervical cancer: women's health and rights.消除宫颈癌的障碍：妇女健康与权利
Int J Gynaecol Obstet. 2007 Jun;97(3):232-4. doi: 10.1016/j.ijgo.2007.03.004. Epub 2007 Apr 23.
9
The path to eliminate cervical cancer in the world and the challenges of professional education.全球消除宫颈癌之路与专业教育面临的挑战
Vaccine. 2012 Nov 20;30 Suppl 4:viii-ix. doi: 10.1016/S0264-410X(12)01437-5.
10
World Health Organization call for action to eliminate cervical cancer globally.世界卫生组织呼吁采取行动在全球消除宫颈癌。
Int J Gynecol Cancer. 2020 Apr;30(4):426-427. doi: 10.1136/ijgc-2020-001285. Epub 2020 Mar 2.
引用本文的文献
1
Management for Cervical Cancer Patients: A Comparison of the Guidelines from the International Scientific Societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO).宫颈癌患者的管理：国际科学学会（ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO）指南比较
Cancers (Basel). 2024 Jul 15;16(14):2541. doi: 10.3390/cancers16142541.
2
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.奈拉替尼治疗 HER2 突变型转移性宫颈癌患者的疗效：SUMMIT 篮子试验的 2 期研究结果。
Gynecol Oncol. 2020 Oct;159(1):150-156. doi: 10.1016/j.ygyno.2020.07.025. Epub 2020 Jul 25.
3
Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis.常规和先进影像学方法在评估新诊断宫颈癌中的诊断性能：系统评价和荟萃分析。
Eur Radiol. 2020 Oct;30(10):5560-5577. doi: 10.1007/s00330-020-06909-3. Epub 2020 May 15.
Zotero 插件